- Associated Press - Monday, January 13, 2014

LITTLE ROCK, Ark. (AP) - The Arkansas Supreme Court has scheduled oral arguments in Johnson & Johnson’s request to overturn a verdict and $1.2 billion fine over the marketing of the antipsychotics drug Risperdal.

Oral arguments are set for Feb. 27 in Little Rock for the appeal from Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, Inc. Attorney General Dustin McDaniel successfully sued the companies, claiming they downplayed and hid risks associated with taking Risperdal.

In 2012, a Pulaski County judge fined the two companies $5,000 for each of 240,000 Risperdal prescriptions the state Medicaid program paid for during a 3½-year period.

In a separate case, Johnson & Johnson agreed to a $2.2 billion settlement with the U.S. Department of Justice in November over allegations that it promoted three drugs, including Risperdal, for off-label uses.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide